Lysozyme overexpression in fundic gland polyps

Carlos A Rubio1

  • 1Gastrointestinal and Liver Pathology Research Laboratory, Department of Pathology, Karolinska Institute and University Hospital, 17176, Stockholm, Sweden. Carlos.Rubio@ki.se

Anticancer Research
|April 16, 2010
PubMed
Abstract

Insights

Fundic gland polyps (FGPs) show high lysozyme expression, potentially explaining why Helicobacter pylori (Hp) rarely proliferates in these patients. This natural defense mechanism warrants further investigation.

Area of Science:

  • Gastroenterology
  • Pathology
  • Microbiology

Background:

  • Helicobacter pylori (Hp) infection is common, but its proliferation is notably rare in patients with fundic gland polyps (FGPs).
  • FGPs exhibit expression of lysozyme, a key component of the innate immune system involved in combating microbial infections.

Purpose of the Study:

  • To investigate and quantify the expression levels of lysozyme in fundic gland polyps (FGPs).
  • To correlate lysozyme expression patterns with the presence or absence of Helicobacter pylori (Hp) infection.

Main Methods:

  • Analysis of 153 gastric biopsies, including FGPs, normal mucosa, Hp-induced gastritis, and non-Hp gastritis.
  • Immunohistochemical staining using anti-lysozyme (muramidase) antibodies to assess lysozyme distribution and intensity.

Main Results:

  • Lysozyme expression was observed in various gastric tissues, with marked expression in neck glands of normal mucosa and gastritis.
  • A higher ratio of lysozyme in neck glands compared to foveoli was noted in non-Hp gastritis and Hp-gastritis.
  • FGPs demonstrated significant lysozyme expression in surface epithelium, foveolar pits, and cyst-lining cells.

Conclusions:

  • The elevated lysozyme production in the epithelium of FGPs may serve as a protective mechanism against Helicobacter pylori proliferation.
  • While lysozyme in gastritis may not be sufficient for bacterial eradication, its overproduction in FGPs offers a potential explanation for the low incidence of Hp infection in these polyps.

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...